DLL3

Source: Wikipedia, the free encyclopedia.
DLL3
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_016941
NM_203486

NM_007866

RefSeq (protein)

NP_058637
NP_982353

NP_031892

Location (UCSC)Chr 19: 39.5 – 39.51 MbChr 7: 27.99 – 28 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Delta-like 3 (Drosophila), also known as DLL3, is a protein which in humans is encoded by the DLL3 gene.[5] Two transcript variants encoding distinct isoforms have been identified for this gene.

Function

This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain.[6] Expression of DLL3 is highest in fetal brain. It plays a key role in somitogenesis within the paraxial mesoderm.[7]

Clinical significance

Mutations in this gene cause the autosomal recessive genetic disorder Jarcho-Levin syndrome.[8] Expression of the gene occurs in Neuroendocrine tumors, which has been targeted as a potential pathway for treatment.[9]

Experimental drugs targetting DLL3 have been investigated as a possible treatment for lung cancer including Tarlatamab and rovalpituzumab tesirine.[10]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000090932Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000003436Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. PMID 10364530
    .
  6. ^ "DLL3 delta like canonical Notch ligand 3 [ Homo sapiens (human) ]".
  7. PMID 21147753
    .
  8. .
  9. .
  10. ^ "Rovalpituzumab tesirine - Stemcentrx - AdisInsight".

External links

Further reading


This page is based on the copyrighted Wikipedia article: DLL3. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy